Strategic Patenting: Evidence from the Biopharmaceutical Industry

Michael D. Frakes and Melissa F. Wasserman

No 34024, NBER Working Papers from National Bureau of Economic Research, Inc

Abstract: Biological drugs account for just two percent of prescriptions filled in the U.S. but fifty percent of prescription-drug spending. To explore the role patents play in explaining high biologics prices, we build the first comprehensive database of patents associated with all FDA-approved biologics. We first establish that much of what drives biologic patenting is the desire to block entry by competing biosimilars. For these purposes, we estimate the response to a 2010 Act that created an abbreviated pathway for biosimilars to receive FDA approval. We then document robust evidence consistent with two patenting strategies that may block biosimilar competition: thicketing and evergreening, whereby firms supplement primary patents with a dense web of later-expiring patents on secondary drug features. We conduct various exercises to suggest that these behaviors are undertaken with exclusionary purposes that go beyond the traditional justifications of the patent system. We then set forth various descriptive statistics surrounding biosimilar entry to suggest that these patenting strategies are, in fact, effective at delaying biosimilar entry. Finally, we simulate the degree to which biologics patent portfolios are impacted by policy proposals currently under consideration to address thicketing and evergreening.

JEL-codes: K0 L50 L65 O34 (search for similar items in EconPapers)
Date: 2025-07
Note: EH IO LE PR
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.nber.org/papers/w34024.pdf (application/pdf)
Access to the full text is generally limited to series subscribers, however if the top level domain of the client browser is in a developing country or transition economy free access is provided. More information about subscriptions and free access is available at http://www.nber.org/wwphelp.html. Free access is also available to older working papers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberwo:34024

Ordering information: This working paper can be ordered from
http://www.nber.org/papers/w34024
The price is Paper copy available by mail.

Access Statistics for this paper

More papers in NBER Working Papers from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().